Literature DB >> 11023038

Geranylgeranylacetone stimulates mucin synthesis in cultured guinea pig gastric pit cells by inducing a neuronal nitric oxide synthase.

K Rokutan1, S Teshima, T Kawai, T Kawahara, K Kusumoro, T Mizushima, K Kishi.   

Abstract

Nitric oxide (NO) has been considered to play an important role in the regulation of blood flow, mucosal integrity, and mucus production in the stomach. We investigated the stimulatory actions of epidermal growth factor (EGF) and a cytoprotective compound, geranylgeranylacetone (GGA), on mucin synthesis in guinea pig gastric pre-pit cells, maintained in a serum-free culture system. GGA increased [3H]glucosamine uptake and the accumulation of mucus granules positive for galactose oxidase-Schiff reaction in the cells. This stimulatory action of GGA was equivalent to that of EGF, but GGA did not stimulate the cell growth. Both EGF and GGA increased the release of NO degeneration products, NO2- and NO3-. The [3H]glucosamine uptake was completely inhibited by the non-selective NO synthase (NOS) inhibitors, N(G)-nitro-L-arginine and N(G)-monomethyl-L-arginine, and it was only partially inhibited by a more selective inhibitor for inducible NOS isoform (iNOS), aminoguanidine. Northern blotting with a cDNA probe for rat iNOS, and Western blotting with a polyclonal antibody against iNOS, demonstrated that GGA did not up-regulate the iNOS mRNA expression nor induce its protein. In contrast, GGA and EGF induced neuronal NOS, but not endothelial NOS, which was confirmed by immunoblot analyses with antibodies against these constitutive NOS isoforms. Thus, the present experiments suggests that GGA, as well as EGF, stimulates mucin synthesis at least in part through an NO-dependent pathway, leading to an increase in the integrity of the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023038     DOI: 10.1007/s005350070046

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  6 in total

1.  Gastric mucosal protection via enhancement of MUC5AC and MUC6 by geranylgeranylacetone.

Authors:  Su Youn Nam; Nayoung Kim; Chang Soo Lee; Kee Don Choi; Hye Seung Lee; Hyun Chae Jung; In Sung Song
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

2.  Influence of geranylgeranylacetone on the expression of HSP70 in retina of rats with chronic IOP elevation.

Authors:  Zhi-Li Liu; Ying-Rong Wang; Qian Sha; Qing-Zhu Nie
Journal:  Int J Ophthalmol       Date:  2010-03-18       Impact factor: 1.779

3.  Geranylgeranylacetone suppresses inflammatory responses and improves survival after massive hepatectomy in rats.

Authors:  Hironobu Oda; Hidenori Miyake; Takashi Iwata; Kenji Kusumoto; Kazuhito Rokutan; Seiki Tashiro
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

4.  Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model.

Authors:  Joseph Caprioli; Yoko Ishii; Jacky M K Kwong
Journal:  Trans Am Ophthalmol Soc       Date:  2003

5.  Gastroprotective action of Cochinchina momordica seed extract is mediated by activation of CGRP and inhibition of cPLA(2)/5-LOX pathway.

Authors:  Jung Mook Kang; Nayoung Kim; Bongcheol Kim; Joo-Hyon Kim; Bong-Yong Lee; Ji Hyun Park; Mi Kyoung Lee; Hye Seung Lee; In-Jin Jang; Joo Sung Kim; Hyun Chae Jung; In Sung Song
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

6.  Integrative roles of transforming growth factor-alpha in the cytoprotection mechanisms of gastric mucosal injury.

Authors:  Takashi Kosone; Hitoshi Takagi; Satoru Kakizaki; Naondo Sohara; Norio Horiguchi; Ken Sato; Masashi Yoneda; Toshiyuki Takeuchi; Masatomo Mori
Journal:  BMC Gastroenterol       Date:  2006-08-01       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.